GSK PLC (LSE:GSK)
£ 18.1 0.105 (0.58%) Market Cap: 73.81 Bil Enterprise Value: 87.49 Bil PE Ratio: 17.87 PB Ratio: 5.33 GF Score: 77/100

GlaxoSmithKline PLC to Discuss Data Presented at ESMO Transcript

Sep 30, 2019 / 05:00PM GMT
Release Date Price: £17.57 (+1.14%)
Operator

A very good day, and welcome to the GSK ESMO Investor Call. (Operator Instructions) I would also like to advise all parties this conference is being recorded. And now, I would like to hand over to Sarah Elton-Farr, Global Head of Investor Relations. Please proceed.

Sarah Elton;Farr;Hal V. Barron
GlaxoSmithKline plc - Head of IR;

Thank you. Good evening, and good afternoon. Thank you for joining our ESMO Investor Call. You can view our slides on the Investor section of the GSK website.

Our speakers today are Dr. Hal Barron, Chief Scientific Officer and President of R&D; Dr. Antonio González-Martín, primary investigator on the PRIMA study and Head of Medical Oncology at the University Clinic of Navarra; Dr. Axel Hoos, Senior Vice President of Oncology R&D; and Luke Miels, President of Global Pharmaceuticals.

We have a broad team on the line for Q&A. Before we start, I would draw your attention to our cautionary statements on Slide 2. And with that, I will hand over to Hal.

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot